AAV - CNGB3: Clinical Trials

1 trial of AAV - CNGB3, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow AAV - CNGB3: new trials by email Literature Review of AAV - CNGB3 trials Research Report on AAV - CNGB3

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Gene Therapy for Achromatopsia (CNGB3)
AAV - CNGB3 - Achromatopsia
Phase 1 / Phase 2CompletedMeiraGTx UK II Ltd232017-01-162023-03-08

Conditions studied

Color Vision Defects (1)

Sponsors

MeiraGTx UK II Ltd (1)

Countries

United Kingdom (1)  ·  United States (1)

Top investigators

James Bainbridge, Prof (1)

Results publications

PMID 37172884

NIH funding

2016 (1)